These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 31244856)

  • 1. The Humoral Immune Response to BCG Vaccination.
    Tanner R; Villarreal-Ramos B; Vordermeier HM; McShane H
    Front Immunol; 2019; 10():1317. PubMed ID: 31244856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination.
    Bitencourt J; Peralta-Álvarez MP; Wilkie M; Jacobs A; Wright D; Salman Almujri S; Li S; Harris SA; Smith SG; Elias SC; White AD; Satti I; Sharpe SS; O'Shea MK; McShane H; Tanner R
    Front Immunol; 2021; 12():798207. PubMed ID: 35069580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.
    van der Heijden EMDL; Chileshe J; Vernooij JCM; Gortazar C; Juste RA; Sevilla I; Crafford JE; Rutten VPMG; Michel AL
    PLoS One; 2017; 12(11):e0188448. PubMed ID: 29155877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revaccination of cattle with bacille Calmette-Guérin two years after first vaccination when immunity has waned, boosted protection against challenge with Mycobacterium bovis.
    Parlane NA; Shu D; Subharat S; Wedlock DN; Rehm BH; de Lisle GW; Buddle BM
    PLoS One; 2014; 9(9):e106519. PubMed ID: 25180583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous administration of a 10-fold-lower dose of a commercial human tuberculosis vaccine, Mycobacterium bovis bacillus Calmette-Guerin Danish, induced levels of protection against bovine tuberculosis and responses in the tuberculin intradermal test similar to those induced by a standard cattle dose.
    Buddle BM; Hewinson RG; Vordermeier HM; Wedlock DN
    Clin Vaccine Immunol; 2013 Oct; 20(10):1559-62. PubMed ID: 23925885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine TB and the development of new vaccines.
    Hope JC; Villarreal-Ramos B
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):77-100. PubMed ID: 17764740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans.
    Buddle BM; Parlane NA; Wedlock DN; Heiser A
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 1():136-46. PubMed ID: 24171859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months.
    Thom ML; McAulay M; Vordermeier HM; Clifford D; Hewinson RG; Villarreal-Ramos B; Hope JC
    Clin Vaccine Immunol; 2012 Aug; 19(8):1254-60. PubMed ID: 22718125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination.
    Guerra-Maupome M; McGill JL
    Sci Rep; 2019 Nov; 9(1):15996. PubMed ID: 31690788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteins.
    Wedlock DN; Keen DL; McCarthy AR; Andersen P; Buddle BM
    Vet Immunol Immunopathol; 2002 May; 86(1-2):79-88. PubMed ID: 11943331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.
    Skinner MA; Buddle BM; Wedlock DN; Keen D; de Lisle GW; Tascon RE; Ferraz JC; Lowrie DB; Cockle PJ; Vordermeier HM; Hewinson RG
    Infect Immun; 2003 Sep; 71(9):4901-7. PubMed ID: 12933831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boosting BCG with inert spores improves immunogenicity and induces specific IL-17 responses in a murine model of bovine tuberculosis.
    Garcia-Pelayo MC; Kaveh DA; Sibly L; Webb PR; Bull NC; Cutting SM; Hogarth PJ
    Tuberculosis (Edinb); 2016 May; 98():97-103. PubMed ID: 27156624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
    Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
    mBio; 2016 May; 7(3):. PubMed ID: 27222470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish.
    Hope JC; Thom ML; McAulay M; Mead E; Vordermeier HM; Clifford D; Hewinson RG; Villarreal-Ramos B
    Clin Vaccine Immunol; 2011 Mar; 18(3):373-9. PubMed ID: 21228141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development.
    Niki M; Suzukawa M; Akashi S; Nagai H; Ohta K; Inoue M; Niki M; Kaneko Y; Morimoto K; Kurashima A; Kitada S; Matsumoto S; Suzuki K; Hoshino Y
    J Immunol Res; 2015; 2015():527395. PubMed ID: 26568961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.